Flowcytometric analysis of tumor tissues showed that the expression of PD‐L1 was decreased in zosuquidar group, and the percentage of tumor‐infiltrated CD3+ and CD8+ T cells were induced with the treatment of zosuquidar or PD‐1 mAb (Figure 3C–E). Here, CD8A is linked to neoplasm.